D-dimer – Understanding the concept and value

Juni 30, 2020

Webinar presented by Guillaume Galpy.

Watch on-demand

About this webinar

Learn more and get answers to your questions on D-dimer - How important is D-dimer in the management of patients with Venous Thromboembolism? What an elevated D-dimer in a COVID-19 patient would mean?

Several research work and publications lately have highlighted the potential prognostic value of numerous biomarkers in COVID-19 patients leading to revised guidelines and recommendations. One such biomarker of high importance is D-dimer. Older age, elevated d-dimer levels (greater than 1 µg/L), and clinical probability assessment, on admission, have been included as risk factors for COVID-19 related mortality1.

About the speaker

Guillaume Galpy:
Having worked on acute care testing for more than 24 years, Guillaume has been a global industry expert in the field of Immunoassay. He is the name behind the launch of the first Troponin I automated assay in 1995 and several other markers such as natriuretic peptides and D-dimer. After Graduating in Biology and Marketing from the University of Nice and Lyon in France, he joined Radiometer and is currently working as a Global Market Development Manager for Immunoassay at Radiometer Medical, Copenhagen.

Who should attend?

  • Critical Care Specialists/Consultants
  • Lab Professionals – Consultants/Managers/Technical Staff
  • Clinical and Biomedical Biochemists
  • Point of care Coordinators


This webinar will describe:

  • What is D-dimer test and how can it be used in practice?
  • What does an elevated D-dimer in COVID-19 patients mean?
  • How to define a high-quality D-dimer assay

1. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28; 395(10229): 1054-1062.

Auf dieser Website werden Cookies verwendet

Verwendung von Cookies